[Current and future use of hemopoietic growth factors].
Reguart
N
N
Servei d'Oncologia Mèdica, Institut Clínic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic de Barcelona, Spain.
Gascón
P
P
D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D017370:Interleukin-11; D009190:Myelodysplastic Syndromes; D009503:Neutropenia
D016298:Hematopoietic Cell Growth Factors; D017370:Interleukin-11; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor